An assessment of the impact of COVID-19 on transplantation practice, one year from the start of the pandemic….
Webinar: COVID-19 & transplantation – one year on
Category: TLJ
Technical & Logistical aspects of Performing Normothermic Regional Perfusion in Controlled Donation after Circulatory Death in Europe
A working group of European experts has summarised the current technique and logistical aspects as they are implemented in their countries and / or centres. From these discussions, and supported by literature, the TJL2.0 Work Stream has created a list of recommendations and minimal requirements any NRP programme should follow. We ask your help to…
The COVID-19 Vaccine Studies
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader…
Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer – Open for comments until 06 April
This pre-print from TLJ 2.0 WS03 on ‘Managing Immunosuppressant Therapy in Potentially Cured Post-Kidney Transplant Cancer’ is now open for comments on Transplant Live. Led by Umberto Maggiore, this paper will be submitted to Transplant International once feedback from our community has been collated. Login & provide your input today…
Scientific Highlights – Transplantation Learning Journey TLJ 2.0
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of TLJ 2.0, this report covers all the highlights from the event, including the key discussion points and outcomes from some of the World’s leading transplant experts. Read the TLJ20Report for the…
EKHA Open Letter to EU Policymakers
EKHA Open Letter to EU Policymakers On Behalf Of The European Organ Donation and Transplantation Community “Life After Covid-19: Time to realise a Second EU Action Plan on Organ Donation and Transplantation” EKHA Open Letter on Organ Donation & Transplantation…
Important outcomes from ESOT TLJ 2.0 highlighted in Lancet
It is highly encouraging to see important outcomes from ESOT TLJ 2.0 highlighted in this article from The Lancet Medical Journal, exploring why people with HIV should join the organ donor register. Paolo Grossi, leader of Workstream 2 – CMV infection and disease – at TLJ 2.0 had stated that given the advances in antiretroviral…
It’s time to prepare your abstract submission for #ESOTcongress
The ESOT Congress serves as a premier platform for researchers from across the globe to present their organ transplantation research, the abstract submission is open, with the following key submission deadlines: Abstract submission: 22 February 2021 Late-breaking abstract submission period: 10-25 May 2021 (preliminary research must be provided by 22 February 2021) Find out more by reading our abstract and clinical…
ESOT TLJ 2.0 replay
If you missed #ESOTTLJ webinars you can now catch up on-demand! Click here and Enjoy! …